{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:09:34Z","timestamp":1787497774155,"version":"build-2736575974"},"reference-count":83,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870003"],"award-info":[{"award-number":["81870003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81925001"],"award-info":[{"award-number":["81925001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhongnanshan Medical Foundation of Guangdong Province","award":["ZNSA-2020013"],"award-info":[{"award-number":["ZNSA-2020013"]}]},{"name":"Shanghai Pujiang Program 2021","award":["21PJD061"],"award-info":[{"award-number":["21PJD061"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2022,2,22]]},"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>\n                    Bronchiectasis is a debilitating chronic suppurative airway disease that confers a substantial burden globally. Despite the notable prevalence, research on bronchiectasis in mainland China remains in its infancy. Nevertheless, there has been a significant leap in the quantity and quality of research, which has contributed to the ever-improving clinical practice. A nationwide collaborative platform has been established to foster multicentre studies, which will help increase the level of evidence further. Here, we summarise the\n                    <jats:italic>status quo<\/jats:italic>\n                    of clinical management and consider the research priorities for bronchiectasis that have been published previously. We also highlight the efforts of the Chinese medical communities to outline the core tasks that need to be addressed within the next decade.\n                  <\/jats:p>","DOI":"10.1183\/23120541.00017-2022","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T11:45:22Z","timestamp":1646912722000},"page":"00017-2022","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Research advances and clinical management of bronchiectasis: Chinese perspective"],"prefix":"10.1183","volume":"8","author":[{"given":"Jin-fu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-lin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-ming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"2024101711313696000_8.2.00017-2022.1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2024101711313696000_8.2.00017-2022.2","first-page":"379","article-title":"[The prevalence and risk factors of bronchiectasis in residents aged 40\u2005years old and above in seven cities in China]","volume":"52","author":"Zhou","year":"2013","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2024101711313696000_8.2.00017-2022.3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.2.420"},{"key":"2024101711313696000_8.2.00017-2022.4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1164\/ajrccm.158.3.9710090","article-title":"Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis","volume":"158","author":"Tsang","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711313696000_8.2.00017-2022.5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1513\/AnnalsATS.201511-740PS","article-title":"Bronchiectasis in China","volume":"13","author":"Lin","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024101711313696000_8.2.00017-2022.6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chron Respir Dis"},{"key":"2024101711313696000_8.2.00017-2022.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00954-2015"},{"key":"2024101711313696000_8.2.00017-2022.8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rmed.2019.04.007","article-title":"Incidence of patients with non-cystic fibrosis bronchiectasis in Germany \u2013 a healthcare insurance claims data analysis","volume":"151","author":"Diel","year":"2019","journal-title":"Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01033-2015"},{"key":"2024101711313696000_8.2.00017-2022.10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rmed.2016.10.014","article-title":"Prevalence and incidence of bronchiectasis in Catalonia, Spain: a population-based study","volume":"121","author":"Monteagudo","year":"2016","journal-title":"Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12890-020-1050-0","article-title":"Prevalence and incidence of bronchiectasis in Italy","volume":"20","author":"Aliberti","year":"2020","journal-title":"BMC Pulm Med"},{"key":"2024101711313696000_8.2.00017-2022.12","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00334-2021"},{"key":"2024101711313696000_8.2.00017-2022.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00194-2019"},{"key":"2024101711313696000_8.2.00017-2022.14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.15","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00081-2015"},{"key":"2024101711313696000_8.2.00017-2022.16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"2024101711313696000_8.2.00017-2022.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0042-3"},{"key":"2024101711313696000_8.2.00017-2022.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01926-2017"},{"key":"2024101711313696000_8.2.00017-2022.19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"2024101711313696000_8.2.00017-2022.22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.5588\/ijtld.14.0613","article-title":"Sputum bacteriology in steady-state bronchiectasis in Guangzhou","volume":"19","author":"Guan","year":"2015","journal-title":"China Int J Tubercul Lung Dis"},{"key":"2024101711313696000_8.2.00017-2022.23","first-page":"625","article-title":"Effect of airway Pseudomonas aeruginosa isolation and infection on steady-state bronchiectasis in Guangzhou, China","volume":"7","author":"Guan","year":"2015","journal-title":"J Thorac Dis"},{"key":"2024101711313696000_8.2.00017-2022.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014613"},{"key":"2024101711313696000_8.2.00017-2022.25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cmi.2018.07.008","article-title":"Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients","volume":"25","author":"Luo","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2024101711313696000_8.2.00017-2022.26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/COPD.S150250","article-title":"Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications","volume":"13","author":"Gao","year":"2018","journal-title":"Int J Chron Obstruct Pulm Dis"},{"key":"2024101711313696000_8.2.00017-2022.27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","article-title":"The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study","volume":"9","author":"Dicker","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.5588\/ijtld.18.0037","article-title":"Proteobacteria community compositions correlate with bronchiectasis severity","volume":"22","author":"Guan","year":"2018","journal-title":"Int J Tubercul Lung Dis"},{"key":"2024101711313696000_8.2.00017-2022.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1961"},{"key":"2024101711313696000_8.2.00017-2022.30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.arbres.2019.12.010","article-title":"The roles of bacteria and viruses in bronchiectasis exacerbation: a prospective study","volume":"56","author":"Chen","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"2024101711313696000_8.2.00017-2022.31","doi-asserted-by":"crossref","first-page":"ofaa235","DOI":"10.1093\/ofid\/ofaa235","article-title":"The role of Epstein-Barr virus in adults with bronchiectasis: a prospective cohort study","volume":"7","author":"Chen","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024101711313696000_8.2.00017-2022.32","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41422-021-00562-1","article-title":"Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2(pos) subjects","volume":"31","author":"Yu","year":"2021","journal-title":"Cell Res"},{"key":"2024101711313696000_8.2.00017-2022.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-004-2520-5"},{"key":"2024101711313696000_8.2.00017-2022.34","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.21037\/jtd.2018.02.13","article-title":"Aberrant epithelial remodeling with impairment of cilia architecture in non-cystic fibrosis bronchiectasis","volume":"10","author":"Chen","year":"2018","journal-title":"J Thorac Dis"},{"key":"2024101711313696000_8.2.00017-2022.35","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41385-018-0013-8","article-title":"Increased intracellular Cl(-) concentration promotes ongoing inflammation in airway epithelium","volume":"11","author":"Zhang","year":"2018","journal-title":"Mucosal Immunol"},{"key":"2024101711313696000_8.2.00017-2022.36","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.162.5.9907064","article-title":"Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis","volume":"162","author":"Shum","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711313696000_8.2.00017-2022.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-829OC"},{"key":"2024101711313696000_8.2.00017-2022.38","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00282402"},{"key":"2024101711313696000_8.2.00017-2022.39","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-211846"},{"key":"2024101711313696000_8.2.00017-2022.40","doi-asserted-by":"crossref","first-page":"106270","DOI":"10.1016\/j.rmed.2020.106270","article-title":"The detrimental qualitative and quantitative alterations of circulating endothelial progenitor cells in patients with bronchiectasis","volume":"176","author":"Liu","year":"2021","journal-title":"Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.rmed.2017.11.024","article-title":"Subclinical atherosclerosis in adults with steady-state bronchiectasis: a case-control study","volume":"134","author":"Gao","year":"2018","journal-title":"Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.42","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/crj.12911","article-title":"Clinical characteristics and validation of bronchiectasis severity score systems for post-tuberculosis bronchiectasis","volume":"12","author":"Wang","year":"2018","journal-title":"Clin Respir J"},{"key":"2024101711313696000_8.2.00017-2022.43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/radiol.2253011575","article-title":"High-resolution CT quantification of bronchiectasis: clinical and functional correlation","volume":"225","author":"Ooi","year":"2002","journal-title":"Radiology"},{"key":"2024101711313696000_8.2.00017-2022.44","first-page":"2982","article-title":"[Correlation between chest CT features and clinical characteristics of patients with bronchiectasis]","volume":"99","author":"Wu","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"2024101711313696000_8.2.00017-2022.45","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.07390"},{"key":"2024101711313696000_8.2.00017-2022.46","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2147\/COPD.S163243","article-title":"High prevalence of bronchiectasis in emphysema-predominant COPD patients","volume":"13","author":"Dou","year":"2018","journal-title":"Int J Chron Obstruct Pulm Dis"},{"key":"2024101711313696000_8.2.00017-2022.47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/COPD.S152447","article-title":"Emphysema and bronchiectasis in COPD patients with previous pulmonary tuberculosis: computed tomography features and clinical implications","volume":"13","author":"Jin","year":"2018","journal-title":"Int J Chron Obstruct Pulm Dis"},{"key":"2024101711313696000_8.2.00017-2022.48","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/COPD.S156126","article-title":"Co-existence of COPD and bronchiectasis: a risk factor for a high ratio of main pulmonary artery to aorta diameter (PA:A) from computed tomography in COPD patients","volume":"13","author":"Dou","year":"2018","journal-title":"Int J Chron Obstruct Pulm Dis"},{"key":"2024101711313696000_8.2.00017-2022.49","first-page":"14","article-title":"Bronchodilator response in adults with bronchiectasis: correlation with clinical parameters and prognostic implications","volume":"8","author":"Guan","year":"2016","journal-title":"J Thorac Dis"},{"key":"2024101711313696000_8.2.00017-2022.50","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201406-280OC"},{"key":"2024101711313696000_8.2.00017-2022.51","doi-asserted-by":"crossref","first-page":"28467","DOI":"10.1038\/srep28467","article-title":"Maximal mid-expiratory flow is a surrogate marker of lung clearance index for assessment of adults with bronchiectasis","volume":"6","author":"Guan","year":"2016","journal-title":"Sci Rep"},{"key":"2024101711313696000_8.2.00017-2022.52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113373"},{"key":"2024101711313696000_8.2.00017-2022.53","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04004"},{"key":"2024101711313696000_8.2.00017-2022.54","first-page":"311","article-title":"[Expert consensus on the diagnosis and treatment of adult bronchiectasis in China]","volume":"44","year":"2021","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2024101711313696000_8.2.00017-2022.55","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024101711313696000_8.2.00017-2022.56","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01610-2019"},{"key":"2024101711313696000_8.2.00017-2022.57","doi-asserted-by":"crossref","first-page":"103587","DOI":"10.1016\/j.ebiom.2021.103587","article-title":"Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis","volume":"72","author":"Liu","year":"2021","journal-title":"EBioMedicine"},{"key":"2024101711313696000_8.2.00017-2022.58","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01264-2018"},{"key":"2024101711313696000_8.2.00017-2022.59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12931-019-1042-x","article-title":"Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial","volume":"20","author":"Qi","year":"2019","journal-title":"Respir Res"},{"key":"2024101711313696000_8.2.00017-2022.60","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205587"},{"key":"2024101711313696000_8.2.00017-2022.61","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1164\/rccm.201910-1972OC","article-title":"Relationship between symptoms, exacerbations, and treatment response in bronchiectasis","volume":"201","author":"Gao","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711313696000_8.2.00017-2022.62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/jtd-20-1282","article-title":"Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study","volume":"13","author":"Lee","year":"2021","journal-title":"J Thorac Dis"},{"key":"2024101711313696000_8.2.00017-2022.63","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.2147\/COPD.S115581","article-title":"Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline","volume":"11","author":"Jeong","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101711313696000_8.2.00017-2022.64","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/resp.12618","article-title":"Association between inhaler use and risk of haemoptysis in patients with non-cystic fibrosis bronchiectasis","volume":"20","author":"Jang","year":"2015","journal-title":"Respirology"},{"key":"2024101711313696000_8.2.00017-2022.65","first-page":"2102184","article-title":"Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial","volume":"8","author":"Jayaram","year":"2021","journal-title":"Eur Respir J"},{"key":"2024101711313696000_8.2.00017-2022.66","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00453-2020"},{"key":"2024101711313696000_8.2.00017-2022.67","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02210-2020"},{"key":"2024101711313696000_8.2.00017-2022.68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60953-2"},{"key":"2024101711313696000_8.2.00017-2022.69","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1937"},{"key":"2024101711313696000_8.2.00017-2022.70","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2290"},{"key":"2024101711313696000_8.2.00017-2022.71","doi-asserted-by":"crossref","first-page":"e90047","DOI":"10.1371\/journal.pone.0090047","article-title":"Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"key":"2024101711313696000_8.2.00017-2022.72","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0872-5"},{"key":"2024101711313696000_8.2.00017-2022.73","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00123.2017"},{"key":"2024101711313696000_8.2.00017-2022.74","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5152\/dir.2017.16454","article-title":"Bronchial artery embolization in hemoptysis: a systematic review","volume":"23","author":"Panda","year":"2017","journal-title":"Diag Intervent Radiol"},{"key":"2024101711313696000_8.2.00017-2022.75","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00270-021-02923-0","article-title":"A nomogram to predict recurrence after bronchial artery embolization for hemoptysis due to bronchiectasis","volume":"44","author":"Yan","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2024101711313696000_8.2.00017-2022.76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12890-018-0638-0","article-title":"Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis","volume":"18","author":"Chandrasekaran","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2024101711313696000_8.2.00017-2022.77","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2024101711313696000_8.2.00017-2022.78","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1139\/cjpp-2020-0522","article-title":"Clinical study of pulmonary CT lesions and associated bronchiectasis in 115 convalescent patients with novel coronavirus pneumonia (COVID-19) in China","volume":"99","author":"Wang","year":"2021","journal-title":"Can J Physiol Pharmacol"},{"key":"2024101711313696000_8.2.00017-2022.79","doi-asserted-by":"crossref","first-page":"1753466621995043","DOI":"10.1177\/1753466621995043","article-title":"Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study","volume":"15","author":"Choi","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"2024101711313696000_8.2.00017-2022.80","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S2213-2600(21)00095-3","article-title":"Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study","volume":"9","author":"Aveyard","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024101711313696000_8.2.00017-2022.81","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.jaip.2021.02.041","article-title":"Chronic Respiratory Diseases and the Outcomes of COVID-19: a nationwide retrospective cohort study of 39,420 cases","volume":"9","author":"Guan","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024101711313696000_8.2.00017-2022.82","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.202105-1137LE","article-title":"The impact of the COVID-19 pandemic on exacerbations and symptoms in bronchiectasis: a prospective study","volume":"204","author":"Crichton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711313696000_8.2.00017-2022.83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arbres.2021.05.009","article-title":"Impact of chronic respiratory diseases on the outcomes of COVID-19","volume":"58","author":"He","year":"2022","journal-title":"Arch Bronconeumol"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00017-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:14:36Z","timestamp":1740356076000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00017-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,4,11]]},"published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1183\/23120541.00017-2022"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00017-2022","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}